Elucidating Design Principles for Engineering Cell‐Derived Vesicles to Inhibit SARS‐CoV‐2 Infection
Open Access
- 7 April 2022
- Vol. 18 (19), e2200125
- https://doi.org/10.1002/smll.202200125
Abstract
The ability of pathogens to develop drug resistance is a global health challenge. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an urgent need wherein several variants of concern resist neutralization by monoclonal antibody (mAb) therapies and vaccine-induced sera. Decoy nanoparticles-cell-mimicking particles that bind and inhibit virions-are an emerging class of therapeutics that may overcome such drug resistance challenges. To date, quantitative understanding as to how design features impact performance of these therapeutics is lacking. To address this gap, this study presents a systematic, comparative evaluation of various biologically derived nanoscale vesicles, which may be particularly well suited to sustained or repeated administration in the clinic due to low toxicity, and investigates their potential to inhibit multiple classes of model SARS-CoV-2 virions. A key finding is that such particles exhibit potent antiviral efficacy across multiple manufacturing methods, vesicle subclasses, and virus-decoy binding affinities. In addition, these cell-mimicking vesicles effectively inhibit model SARS-CoV-2 variants that evade mAbs and recombinant protein-based decoy inhibitors. This study provides a foundation of knowledge that may guide the design of decoy nanoparticle inhibitors for SARS-CoV-2 and other viral infections.Funding Information
- National Science Foundation (1844219, 1844336)
- National Institutes of Health (T32GM008449)
This publication has 74 references indexed in Scilit:
- Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional propertiesNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Differential fates of biomolecules delivered to target cells via extracellular vesiclesProceedings of the National Academy of Sciences of the United States of America, 2015
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug DeliveryNano Letters, 2014
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike ProteinJournal of Virology, 2014
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Inhibition of Influenza Virus Infection by Multivalent Sialic‐Acid‐Functionalized Gold NanoparticlesSmall, 2010
- Inhibition of HSV‐1 Attachment, Entry, and Cell‐to‐Cell Spread by Functionalized Multivalent Gold NanoparticlesSmall, 2010
- Kinetic Analyses of Stability of Simple and Complex Retroviral VectorsVirology, 2001
- Studies of Vesicle ExtrusionLangmuir, 1999
- Dose-Dependent Transduction of Vesicular Stomatitis Virus G Protein-Pseudotyped Retrovirus Vector into Human Solid Tumor Cell Lines and Murine FibroblastsVirology, 1999